Possible Warfarin Failure Due to Interaction with Smokeless Tobacco

Annals of Pharmacotherapy

Volumn 38, Issue 4, 2004, Pages 595-597

  Kuykendall, Jim R ^a   Houle, Michael D ^b   Rhodes, Richard S ^c  

^a OHIO NORTHERN UNIVERSITY   (United States)

^b Franciscan Health System   (United States)

^c IDAHO STATE UNIVERSITY   (United States)

Author keywords

Cytochrome P450; Myocardial infarction; Stroke; Tobacco; Vitamin K; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; CARBAMAZEPINE; CLOPIDOGREL; CYTOCHROME P450 2C9; LORAZEPAM; TICLOPIDINE; VITAMIN K GROUP; WARFARIN;

ADULT; ANTICOAGULATION; ARTICLE; CASE REPORT; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG ANTAGONISM; DRUG EFFECT; FOLLOW UP; HEART INFARCTION; HUMAN; MALE; PANIC; PRIORITY JOURNAL; SEIZURE; SMOKELESS TOBACCO; SMOKING CESSATION; SYMPTOM; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK; TREATMENT FAILURE;

ADULT; ANTICOAGULANTS; CEREBROVASCULAR ACCIDENT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ANTAGONISM; HUMANS; INTERNATIONAL NORMALIZED RATIO; ISCHEMIC ATTACK, TRANSIENT; MALE; MYOCARDIAL INFARCTION; THROMBOEMBOLISM; TOBACCO, SMOKELESS; TREATMENT FAILURE; WARFARIN;

EID: 1542639506     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1D087     Document Type: Article

References (7)

1. Israels LG, Israels ED. Observations on vitamin K deficiency in the fetus and newborn: has nature made a mistake? Semin Thromb Hemostat 1955;21:357-63.
2. Olson R. Vitamin K. In: Shils ME, Olson JA, Shike M, eds. Modern nutrition in health and disease. 8th ed. Volume 1. Philadelphia: Lea & Febiger, 1994:342-57.
3. Olsen JA. Recommended daily intakes (RDI) of vitamin K in humans. Am J Clin Nutr 1987;45:687-92.
4. London SJ, Daly AK, Leathart JB, Navidi WC, Idle JR. Lung cancer risk in relation of the CYP2C9*1/CYP2C9*2 genetic polymorphism among African-Americans and Caucasians in Los Angeles County, California. Pharmacogenetics 1996;6:527-33.
5. Miller LG. Recent developments in the study of the effects of cigarette smoking on clinical pharmacokinetics and clinical pharmacodynamics. Clin Pharmacokinet 1989;17:90-108.
6. May JR, DiPiro JT, Sisley JF. Drug interactions in surgical patients. Am J Surg 1987;153:327-35.
7. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.